Immediate Impact

2 from Science/Nature 59 standout
Sub-graph 1 of 22

Citing Papers

Prostate Cancer
2025 Standout
Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
2 intermediate papers

Works of Venu Chalasani being referenced

Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross‐sectional study of the additive diagnostic value of gallium‐68 prostate‐specific membrane antigen positron‐emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer
2020
Integrin-Free Tetraspanin CD151 Can Inhibit Tumor Cell Motility upon Clustering and Is a Clinical Indicator of Prostate Cancer Progression
2013

Author Peers

Author Last Decade Papers Cites
Venu Chalasani 702 404 310 70 1.2k
Fouad Aoun 675 288 210 97 1.2k
Graeme S. Steele 724 496 241 54 1.2k
Paul Cathcart 1052 333 318 66 1.5k
Alberto Saita 748 484 281 111 1.2k
Ali Rıza Kural 1054 385 242 83 1.4k
S. Vincendeau 891 295 235 91 1.2k
Niranjan Sathianathen 868 446 235 91 1.4k
J. Biserte 475 484 220 90 1.0k
Jason Hafron 826 329 253 109 1.3k
Sanoj Punnen 990 440 230 97 1.7k

All Works

Loading papers...

Rankless by CCL
2026